Epiminder Limited (ASX:EPI)

Australia · Delayed Price · Currency is AUD

0.3500

-0.0150 (-4.11%)

At close: Aug 28, 2026

Market Cap	75.72M
Revenue (ttm)	2.13M -87.5%
Net Income	-42.73M
EPS	-0.28
Shares Out	216.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,424
Open	0.3650
Previous Close	0.3650
Day's Range	0.3500 - 0.3650
52-Week Range	0.2500 - 1.4900
Beta	n/a
Analysts	Buy
Price Target	2.20 (+528.57%)
Earnings Date	Aug 31, 2026

About Epiminder

Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company’s Minder system comprises Minder implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder wearable, which receives and stores EEG recordings wireles... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol EPI

Full Company Profile

Financial Performance

In fiscal year 2025, Epiminder's revenue was 445,183, a decrease of -91.52% compared to the previous year's 5.25 million. Losses were -31.78 million, 91.5% more than in 2024.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for EPI stock is "Buy." The 12-month stock price target is $2.20, which is an increase of 528.57% from the latest price.

Price Target

$2.20

(528.57% upside)

Analyst Consensus: Buy

Stock Forecasts